Kintara Therapeutics Stock (NASDAQ:KTRA)


OwnershipFinancialsChart

Previous Close

$0.23

52W Range

$0.20 - $26.21

50D Avg

$6.67

200D Avg

$6.02

Market Cap

$11.99M

Avg Vol (3M)

$83.39K

Beta

0.81

Div Yield

-

KTRA Company Profile


Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1

IPO Date

Feb 22, 2013

Website

KTRA Performance


KTRA Financial Summary


Jun 24Jun 23Jun 22
Revenue---
Operating Income$-8.50M$-14.81M$-22.69M
Net Income$-8.50M$-14.65M$-22.62M
EBITDA$-8.50M$-14.75M$-22.63M
Basic EPS$-0.32$-9.04$-23.22
Diluted EPS$-0.32$-9.04$-23.22

Fiscal year ends in Jun 24 | Currency in USD

Peer Comparison


TickerCompany
GOVXGeoVax Labs, Inc.
DYAIDyadic International, Inc.
FRTXFresh Tracks Therapeutics, Inc.
SABSSAB Biotherapeutics, Inc.
LSTALisata Therapeutics, Inc.
SCPHscPharmaceuticals Inc.
TOVXTheriva Biologics, Inc.
MCRBSeres Therapeutics, Inc.
FWBIEntero Therapeutics, Inc.
BOLTBolt Biotherapeutics, Inc.
VCNXVaccinex, Inc.
KAKineta, Inc.
ONCYOncolytics Biotech Inc.
DMACDiaMedica Therapeutics Inc.
SLRXSalarius Pharmaceuticals, Inc.
MISTMilestone Pharmaceuticals Inc.
LIFEaTyr Pharma, Inc.
CLRBCellectar Biosciences, Inc.
FBRXForte Biosciences, Inc.
LBPHLongboard Pharmaceuticals, Inc.
LUMOLumos Pharma, Inc.